Funded Grants

PI Name PI Organization Title Grant Number Initiative Program Official
Yun, Jihye

University Of Tx Md Anderson Can Ctr
United States

Impact of sugary drinks on gut microbiota and development of young-onset colorectal cancer 7R21CA258134-02 RFA-CA-20-005 (R21 Clinical Trial Optional)
Zhou, Eric S

Dana-Farber Cancer Inst
United States

A Preventive Care Approach to Mitigate the Impact of Pediatric ALL Treatment on Sleep 5R03CA259894-02
Roberts, Steven A

University Of Vermont & St Agric College
United States

Characterizing the contribution of transcription-associated DNA-topoisomerase adducts to mutagenesis in cancer 7R21CA264086-03 PAR-19-252 (R21 Clinical Trial Optional)
Balbo, Silvia

University Of Minnesota
United States

The DNA adductome of lung carcinogenesis 5R01CA220376-05 Wendy Wang, Ph.D., M.Sc.
Putluri, Nagireddy

Baylor College Of Medicine
United States

Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers 5R01CA216426-05 Wendy Wang, Ph.D., M.Sc.
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery 3U01CA152990-10S2 Christos Patriotis, Ph.D., M.Sc.
Yi-Frazier, Joyce P

Seattle Children'S Hospital
United States

The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults receiving Hematopoietic Cell Transplantation 3R01CA225629-05S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fan, Daping

University Of South Carolina At Columbia
United States

Emodin as a chemopreventive agent for breast cancer 3R01CA218578-05S1 Sharon Ross, Ph.D., M.P.H.
Neuhouser, Marian L

Fred Hutchinson Cancer Center
United States

Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository 6U01CA167462-10 Marjorie Perloff, M.D.
Liby, Karen T.

Michigan State University
United States

Nrf2, immune cells and lung cancer 5R01CA226690-05
Jatoi, Aminah

Mayo Clinic Rochester
United States

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients 5R01CA207183-06 Ellen Richmond, M.S., G.N.P.-B.C.
Abyzov, Alexej

Mayo Clinic Rochester
United States

Detection of somatic, subclonal and mosaic CNVs from sequencing 5U24CA220242-05 Christos Patriotis, Ph.D., M.Sc.
Kingham, T Peter

Sloan-Kettering Inst Can Research
United States

Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries 5UH3CA257869-05 Matthew Young, Ph.D.
Mcdonald, Andrew M

University Of Alabama At Birmingham
United States

A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer 5R21CA259808-02
Robien, Kimberly Z

George Washington University
United States

Body composition and chemotherapy toxicity among women being treated for breast cancer 5R21CA259790-02 Sharon Ross, Ph.D., M.P.H.
Zhou, Chuan

University Of Michigan At Ann Arbor
United States

Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer 5U01CA216459-05 PAR-16-089 (U01) Guillermo Marquez, Ph.D.
Crott, Jimmy W

Boston University Medical Campus
United States

Identifying the active factor of an anti-inflammatory chemopreventive bacterium 7R21CA253392-02 Young Kim, Ph.D.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Findlay, Victoria Jane

Virginia Commonwealth University
United States

The effects of time restricted feeding on AGE-RAGE signaling in women at high risk for breast cancer 7R21CA258139-02 Edward Sauter, M.D., Ph.D.
Agarwal, Rajesh

University Of Colorado Denver
United States

Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy 3R01CA140368-10S1 PA-20-227 (Admin Supp-Clinical Trial Not Allowed) Amit Kumar, Ph.D.
Buchanan, Adam H

Geisinger Clinic
United States

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS 5U01CA240747-04 PAR-18-616 (U01 Clinical Trial Optional)
Chen, Ru

Baylor College Of Medicine
United States

Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis 5R01CA211892-06 Matthew Young, Ph.D.
Jim, Heather S.L.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue 5R01CA214647-05 Marge Good, R.N., M.P.H., O.C.N.
Augenlicht, Leonard H

Albert Einstein College Of Medicine
United States

A Major Nutritional Effect on Intestinal Stem Cells and Tumors 5R01CA214625-06 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Wu, Xiangwei

University Of Tx Md Anderson Can Ctr
United States

Activating p53 for colorectal cancer prevention 5R01CA214954-06
Chauhan, Subhash C.

University Of Texas Rio Grande Valley
United States

MUC13 Mucin in Colerectal Cancer Health Disparity 5R01CA204552-05 Matthew Young, Ph.D.
Augenlicht, Leonard H

Albert Einstein College Of Medicine
United States

Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis 5R01CA222358-06 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Augenlicht, Leonard H

Albert Einstein College Of Medicine
United States

Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells 5R01CA229216-06 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Nautiyal, Shivani

Prime Genomics, Inc.
United States

Device for Preservation of Cell Free RNA in Saliva 5R21CA258013-02 Guillermo Marquez, Ph.D.
Arcaro, Kathleen Frances

University Of Massachusetts Amherst
United States

Fruit and vegetable intervention in lactating women to reduce breast cancer risk: effects on breast cell DNA methylation, breast inflammation, and weight 5R01CA230478-05
Abrams, Julian

Columbia University Health Sciences
United States

The Oral Microbiome for the Detection of Barretts Esophagus 5R01CA238433-05
Brennan, Paul Joseph

International Agency For Res On Cancer
United States

PROMINENT - IARC 3OT2CA278681-01S1
Balmain, Allan

University Of California, San Francisco
United States

PROMINENT - UCSF 3OT2CA278665-01S1
Counter, Christopher M

Duke University
United States

PROMINENT-DUKE 3OT2CA278661-01S1
Lopez-Bigas, Nuria

Fundacio Institut De Recerca Biomedica
United States

PROMINENT - IRB 3OT2CA278668-01S1
Lundberg, Emma

Stanford University
United States

PROMINENT - Stanford 3OT2CA278713-01S1
Gunter, Marc James

Imperial College Of Science, Technology And Medicine
United States

PROMINENT: Discovering the molecular signatures of cancer PROMotion to INform prevENTion 1OT2CA290880-01
Conley, Yvette P

University Of Pittsburgh At Pittsburgh
United States

Epigenomics of Neurocognitive Function in Breast Cancer 5R01CA221882-05
Wen, Kuang-Yi

Thomas Jefferson University
United States

A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors 5R01CA222246-05
Hinds, Pamela S

Children'S Research Institute
United States

Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment 5R01CA212190-05
Soragni, Alice

University Of California Los Angeles
United States

Targeting p53 conformational defects to arrest carcinogenesis 5R01CA240718-05
Stolley, Melinda R

Medical College Of Wisconsin
United States

Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors 3R01CA229546-05S1 Sharon Ross, Ph.D., M.P.H.
Valdez, Erin G

Stanford University
United States

Circadian regulation of cancer therapy-associated neuroinflammation 5R21CA267135-02 PAR-20-292 (R21 Clinical Trial Optional)
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 PAR-20-292 (R21 Clinical Trial Optional)
Kober, Kord Michael

University Of California, San Francisco
United States

An Evaluation of Cloud Computing for Symptom Science Research: Moving Genomics and Machine Learning Analyses of Cancer Chemotherapy-Related Fatigue to the Cloud 3R37CA233774-05S1
Fortier, Michelle

University Of California-Irvine
United States

Innovative Pain and Symptom Management Program for Children with Cancer 3R01CA222012-05S1
Kupfer, Sonia

University Of Chicago
United States

Colonic responses to vitamin D and aspirin in African- and European-Americans 5R01CA220329-05 Gabriela Riscuta, M.D., C.N.S.
Turesky, Robert J.

University Of Minnesota
United States

DNA adductomics of the urinary system 5R01CA220367-06 Wendy Wang, Ph.D., M.Sc.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer 5R21CA245651-03 Matthew Young, Ph.D.
Permuth, Jennifer B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 5R37CA229810-05
Dantzer, Robert

University Of Tx Md Anderson Can Ctr
United States

The Metabolic Basis of Cancer-Related Fatigue 5R01CA193522-09
Bissonnette, Bruce Marc

University Of Chicago
United States

CXCR4 as a target for colon cancer chemoprevention 5R01CA240710-05
Heinrich, Michael C

Oregon Health & Science University
United States

Novel models for functional profiling of germline SDH variants associated with cancer 5R21CA263400-02 PAR-20-292 (R21 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
Chang, Su-Hsin

Washington University
United States

Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective 5R01CA253475-03 Asad Umar, D.V.M., Ph.D.
Wu, Bechien

Kaiser Foundation Research Institute
United States

PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT) 5R01CA230442-05
Maitra, Anirban

University Of Tx Md Anderson Can Ctr
United States

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies 5R01CA218230-05 PAR-16-276 (R01) Matthew Young, Ph.D.
Mao, Jun J

Sloan-Kettering Inst Can Research
United States

Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors 5R21CA274059-02
Kuhs, Krystle A.

University Of Kentucky
United States

Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer 5R21CA267152-02
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05
Kalluri, Raghu

University Of Tx Md Anderson Can Ctr
United States

Rigorous and reproducible mutational analysis of the urinary exosomal DNA 5R01CA231465-05
Mckeon, Frank D.

University Of Houston
United States

Clonal Reconstruction and Targeting of the Correa Sequence 5R01CA241600-05
Faris, Gregory W

Numentus Technologies Inc.
United States

Decoding Individual Exosomes in Cancer 5R21CA236686-02
Bea, Jennifer Wright

University Of Arizona
United States

Adipose and Lean Soft Tissue Depots, Cancer Risk and Mortality in Postmenopausal Women 3R01CA253302-03S1 Edward Sauter, M.D., Ph.D.
Yennu, Sriram

University Of Tx Md Anderson Can Ctr
United States

Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients 5R21CA252446-02
Tamrazi, Benita

Children'S Hospital Of Los Angeles
United States

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors 5R21CA262978-02
Xing, Chengguo

University Of Florida
United States

Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation 5R03CA273467-02
Moyer, Matthew T.

Pennsylvania State Univ Hershey Med Ctr
United States

CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial 5R01CA222648-05 Asad Umar, D.V.M., Ph.D.
Mustian, Karen M.

University Of Rochester
United States

Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice 3UG1CA189961-10S1
Rohan, Thomas E

Albert Einstein College Of Medicine
United States

Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ 5R01CA218429-06 Christos Patriotis, Ph.D., M.Sc.
Visovsky, Constance G.

University Of South Florida
United States

Home-Based Physical Activity Intervention for Taxane-Induced CIPN 5R01CA229681-05 Goli Samimi, Ph.D., M.P.H.
Hall, Adam Roger

Wake Forest University Health Sciences
United States

Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores 1R33CA246448-01A1 RFA-CA-19-020 (R33 Clinical Trials Not Allowed) Guillermo Marquez, Ph.D.
Agsalda-Garcia, Melissa Anne

University Of Hawaii At Manoa
United States

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients 1R21CA244078-01 PAR-18-020 (R21 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Kim, Kyungmann

University Of Wisconsin-Madison
United States

CP-CTNet Coordinating Center 5U24CA242637-05 RFA-CA-18-030 (U24 Clinical Trials Required) Donald Johnsey
Toriola, Adetunji T

Washington University
United States

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention 5R37CA235602-05
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 5U01CA214263-05
Ochoa, Augusto C.

Lsu Health Sciences Center
United States

Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) 3UG1CA189854-10S1
Kulkarni, Swati

Northwestern University At Chicago
United States

Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ 5R01CA218436-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Salvemini, Daniela

Saint Louis University
United States

A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity 5R01CA230512-05
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States 5U01CA230694-05
Hecht, Stephen S

University Of Minnesota
United States

Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens 5R01CA222005-05 Amit Kumar, Ph.D.
Wu, Yun

State University Of New York At Buffalo
United States

Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection 5R21CA267934-02 PAR-20-292 (R21 Clinical Trial Optional)
Tangen, Catherine M.

Fred Hutchinson Cancer Center
United States

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research 5U01CA182883-11
King, Suzanne N

University Of Louisville
United States

Mechanisms underlying radiation-induced dysphagia 5R21CA263107-02 PAR-20-292 (R21 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Ladas, Elena J.

Columbia University Health Sciences
United States

Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer 5R01CA201788-07 Gabriela Riscuta, M.D., C.N.S.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 5R37CA231522-06 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sirica, Alphonse E

Federation Of Amer Soc For Exper Biology
United States

The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine 1R13CA284494-01 Wendy Wang, Ph.D., M.Sc.
Deng, Youping

University Of Hawaii At Manoa
United States

Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms 5R01CA230514-05
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer 5R01CA227602-05
Rosenberg, Abby R

Dana-Farber Cancer Inst
United States

The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer 7R01CA222486-06 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Grueber, Wesley B

Columbia University Health Sciences
United States

Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy 5R21CA274588-02
You, Ming

Methodist Hospital Research Institute
United States

Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer 5R01CA223804-05
Patel, Abhijit

Yale University
United States

Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood 5U01CA233364-05
Carter, Bob S

Massachusetts General Hospital
United States

Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas 5U01CA230697-05
Cope, Timothy C

Georgia Institute Of Technology
United States

Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy 5R01CA221363-05
Agarwal, Ashutosh

University Of Miami School Of Medicine
United States

A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer 5U01CA233363-05
Lee, Hakho

Massachusetts General Hospital
United States

Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics 5U01CA233360-05
Wheeler, Stephanie Brooke

Univ Of North Carolina Chapel Hill
United States

Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions 5R01CA237357-05 PA-18-004 (R01 Clinical Trial Optional)
Largaespada, David Andrew

University Of Minnesota
United States

Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention 5UH3CA244687-05 RFA-CA-19-012
Armstrong, Gregory

St. Jude Children'S Research Hospital
United States

Sen-Survivors: An open-label intervention trial for frailty and senescence 1U01CA246510-01 Eileen Dimond, R.N., M.S.
Allen, Peter J

Duke University
United States

Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) 5R01CA235677-05
Rapaport, Mark Hyman

University Of Utah
United States

Massage for Prostate Cancer-Related Fatigue 1R21CA263453-01 PAR-20-292 (R21 Clinical Trial Optional) Goli Samimi, Ph.D., M.P.H.
Kleckner, Ian Robert

University Of Maryland Baltimore
United States

Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation 5R21CA259422-02 PAR-20-292 (R21 Clinical Trial Optional)
Stabile, Laura P.

University Of Pittsburgh At Pittsburgh
United States

Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis 5R21CA259787-02 PAR-20-292 (R21 Clinical Trial Optional)
Davis, Jennifer Sarah

University Of Kansas Medical Center
United States

Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype 7U01CA222163-04 Claire Zhu, Ph.D.
Park, Kwon-Sik

University Of Virginia
United States

Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC 5U01CA224293-05 Eva Szabo, M.D.
Weaver, Alissa M

Vanderbilt University
United States

Phenotype Interactions in SCLC Development and Detection 5U01CA224276-05 Eva Szabo, M.D.
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future 5R01CA227576-05 Eileen Dimond, R.N., M.S.
Beane, Jennifer Ellen

Boston University Medical Campus
United States

PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning 1R21CA253498-01 Guillermo Marquez, Ph.D.
Ghosh, Moumita

University Of Colorado Denver
United States

(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution 5R01CA219893-06 Eva Szabo, M.D.
Lin, Po-Ju

University Of Rochester
United States

Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy 1R21CA256154-01A1 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.
Hoffman, Amy Jude

University Of Nebraska Medical Center
United States

Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients 5R01CA205025-06
Dryden-Peterson, Scott Lee

Brigham And Women'S Hospital
United States

A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation 5R01CA236546-05
Ogilvie, Gina

University Of British Columbia
United States

Addressing emerging health system priorities in cervical cancer prevention: determining optimal strategies for human papillomavirus test-based screening and triage 5R01CA221918-05 Claire Zhu, Ph.D.
Altorki, Nasser Khaled

Weill Medical Coll Of Cornell Univ
United States

Intercepting progression from pre-invasive to invasive lung adenocarcinoma 3UH3CA244697-05S1
Perelman, Lev T

Beth Israel Deaconess Medical Center
United States

Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression 5R01CA228029-06
Lin, Daniel W.

Fred Hutchinson Cancer Center
United States

Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research 5U01CA224255-06
Kassie, Fekadu

University Of Minnesota
United States

Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells 5R01CA231210-05
Krasnow, Mark A

Stanford University
United States

Molecular mechanisms of SCLC initiation and detection in mice and humans 5U01CA231851-05 Eva Szabo, M.D.
Lok, Anna S.F.

University Of Michigan At Ann Arbor
United States

NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION 5U01CA230669-05
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance 5R01CA231283-05 Asad Umar, D.V.M., Ph.D.
Chung, Fung-Lung

Georgetown University
United States

gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention 5U01CA220477-05 Wendy Wang, Ph.D., M.Sc.
Mehta, Anand S

Medical University Of South Carolina
United States

Translation of a biomarker panel for the early detection of hepatocellular carcinoma 5R01CA237659-05
Perlis, Michael Lloyd

University Of Pennsylvania
United States

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients 1R21CA270987-01 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

Neoantigen Vaccination for Lynch Syndrome Immunoprevention 5U01CA233056-05 Mark Steven Miller, Ph.D.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma 1R61CA280978-01
Mishra, Lopa

Feinstein Institute For Medical Research
United States

Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer 7U01CA230690-06
Meltzer, Stephen J

Johns Hopkins University
United States

Facile screening for esophageal cancer in LMICs 5UH3CA211457-05 Matthew Young, Ph.D.
Dasgupta, Piyali

Marshall University
United States

Capsaicin and small cell lung cancer therapy 2R15CA161491-03 Gabriela Riscuta, M.D., C.N.S.
Reese, Jennifer Barsky

Research Inst Of Fox Chase Can Ctr
United States

Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention 5R01CA222124-05 Ellen Richmond, M.S., G.N.P.-B.C.
Curiel-Lewandrowski, Clara

University Of Arizona
United States

Targeted Prevention for Non-Melanoma Skin Cancer 5P01CA229112-05 PAR-18-290 (P01 Clinical Trial Optional)
Anderson, Karen S.

Arizona State University-Tempe Campus
United States

Rapid Point of Care Detection of HPV-Associated Malignancies 5UH3CA211415-06 Christos Patriotis, Ph.D., M.Sc.
Bylund, Carma L.

University Of Florida
United States

Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators 5R01CA253330-03
Deng, Youping

University Of Hawaii At Manoa
United States

Profiling genome-wide circulating ncRNAs for the early detection of lung cancer 5R01CA223490-05
Demehri, Shadmehr

Massachusetts General Hospital
United States

Epithelium-derived alarmins role in breast cancer immunoprevention 5U01CA233097-05 Mark Steven Miller, Ph.D.
Nyante, Sarah Jane

Univ Of North Carolina Chapel Hill
United States

Understanding the biological basis for the association between parenchymal texture features and breast cancer risk 5R01CA237129-05
Cole, Peter D

Rutgers Biomedical And Health Sciences
United States

Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL 7R01CA220568-05
Ragin, Camille C

Research Inst Of Fox Chase Can Ctr
United States

Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry 1R13CA284826-01
Coleman, William B

American Society/Investigative Pathology
United States

2023 Annual Meeting of the American Society for Investigative Pathology 1R13CA284830-01
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Reverse-engineering precision liver cancer chemoprevention 3R01CA233794-05S1
Spira, Avrum E

Boston University Medical Campus
United States

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy 1U2CCA233238-01 Richard Mazurchuk, Ph.D.
Coffey, Robert J.

Vanderbilt University Medical Center
United States

Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation 3U2CCA233291-01S2 Richard Mazurchuk, Ph.D.
Snyder, Michael P.

Stanford University
United States

Precancer Atlas of Familial Adenomatous Polyposis 3U2CCA233311-01S1 Richard Mazurchuk, Ph.D.
Hwang, Eun-Sil Shelley

Duke University
United States

Breast Pre-Cancer Atlas Center 3U2CCA233254-01S3 Richard Mazurchuk, Ph.D.
Sorger, Peter Karl

Harvard Medical School
United States

Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center) 3U2CCA233262-01S2 Sudhir Srivastava, Ph.D., M.P.H.
Penedo, Frank J

University Of Miami Coral Gables
United States

eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients 5R61CA263335-02
Umbricht, Christopher B

Johns Hopkins University
United States

Discovery and validation of early molecular breast cancer risk markers in benign breast disease 5R01CA222779-06
Shen, Chan

Pennsylvania State Univ Hershey Med Ctr
United States

The effects of hydrocodone rescheduling on pain management of older lung cancer patients 1R21CA277849-01
Tighiouart, Mourad

Cedars-Sinai Medical Center
United States

Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials 3U01CA232859-05S1
Mohile, Supriya G

University Of Rochester
United States

Understanding Treatment Tolerability in Older Patients with Cancer 3U01CA233167-05S1
Basch, Ethan M.

Univ Of North Carolina Chapel Hill
United States

Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability 3U01CA233046-05S1
Gray, Robert J

Dana-Farber Cancer Inst
United States

Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) 3U01CA233169-05S1
You, Ming

Methodist Hospital Research Institute
United States

Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-05
Levine, Jon David

University Of California, San Francisco
United States

Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress 5R01CA250017-05
Nechiporuk, Alex

Oregon Health & Science University
United States

High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. 1R21CA260025-01A1 Rachel Altshuler, Ph.D.
Melemedjian, Ohannes Kevork

University Of Maryland Baltimore
United States

Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy 1R01CA249939-01
Duncavage, Eric J

Washington University
United States

Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes 1UH2CA272904-01
Enzinger, Andrea C

Dana-Farber Cancer Inst
United States

Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies 5R21CA270069-02
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2
Peters, Jeffrey M

Pennsylvania State University, The
United States

Unique targeting of PPARβ/δ regulation for cancer prevention and therapy 5R01CA239256-05
Katona, Bryson William

University Of Pennsylvania
United States

Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants 5R21CA267949-02 PAR-20-292 (R21 Clinical Trial Optional)
Yennu, Sriram

University Of Tx Md Anderson Can Ctr
United States

A Combination Therapy to Treat Cancer-Related Fatigue 5R01CA231521-05
Crew, Katherine D

Columbia University Health Sciences
United States

Multicenter trial of decision support for breast cancer chemoprevention 3R01CA226060-05S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
You, Ming

Methodist Hospital Research Institute
United States

Inhibition of Oral Tumorigenesis by Antitumor B 7R01CA205633-06 Eva Szabo, M.D.
Sedrak, Mina S

University Of California Los Angeles
United States

Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors 5R21CA277660-03
Houghton, A Mcgarry

Fred Hutchinson Cancer Center
United States

Tumor-specific autoantibodies for SCLC early detection 5R01CA243328-06
Figueiredo, Jane C.

Cedars-Sinai Medical Center
United States

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 3U54CA260591-02S3
Rodriguez, Gustavo

Northshore University Healthsystem
United States

Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer 3R01CA214606-05S1 Marjorie Perloff, M.D.
Badu-Tawiah, Abraham

Ohio State University
United States

Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening 5R21CA270727-02 PAR-20-292 (R21 Clinical Trial Optional)
Marchetti, Dario

University Of New Mexico Health Scis Ctr
United States

Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF 5R01CA216991-07
Noble, Mark D

University Of Rochester
United States

Prevention and treatment of paclitaxel-induced peripheral neuropathy 5R21CA277447-02
Morilak, David A

University Of Texas Hlth Science Center
United States

Cognitive impairment associated with androgen deprivation therapy for prostate cancer 5R01CA224672-05
Fan, Rong

Yale University
United States

Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies 3U01CA260507-02S2
Mantis, Nicholas J.

Wadsworth Center
United States

High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology 3U01CA260508-02S1
Darie, Costel C.

Clarkson University
United States

PA-21-071 for Pathea Bruno to CA260126-01 Identifying a proteomic signature for breast cancer detection in breast milk and serum 3R15CA260126-01A1S1
Kahalley, Lisa Schum

Baylor College Of Medicine
United States

White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy 5R01CA221197-05
Smalley, Keiran

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Defining and targeting the epigenetic programs involved in melanoma development 5R21CA267141-02 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.
Cao, Lei

Ohio State University
United States

Cancer prevention and treatment by activation of a brain-adipocyte axis 5R01CA166590-10 Winfred Malone, Ph.D., M.P.H.
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy 5R03CA277194-02
Zeng, Melody Yue

Weill Medical Coll Of Cornell Univ
United States

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis 5R21CA270998-02
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis 5R01CA222900-06
Nathan, Cherie-Ann O

Louisiana State Univ Hsc Shreveport
United States

Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma. 5R01CA217180-05
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. 5R21CA270702-02 PAR-20-292 (R21 Clinical Trial Optional)
Hofseth, Lorne J

University Of South Carolina At Columbia
United States

Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer 3R01CA246809-05S1
Degnim, Amy C

Mayo Clinic Rochester
United States

Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia 5R01CA237607-05
Singh, Shivendra

University Of Pittsburgh At Pittsburgh
United States

Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer 5R01CA225716-05
Thomas, Christoforos

Methodist Hospital Research Institute
United States

Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome 5R21CA267386-03 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.
Pandharipande, Pari Vijay

Ohio State University
United States

Precision Management of Cystic Precursors to Pancreatic Cancer 5R01CA237133-06 Matthew Young, Ph.D.
Smith, Ellen Mary Lavoie

University Of Alabama At Birmingham
United States

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study 5R01CA235726-07
Hayes, Richard Bernard

New York University School Of Medicine
United States

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer 5R01CA159036-09
Somers, Tamara J

Duke University
United States

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial 5R01CA237892-05
Porter, Laura S

Duke University
United States

Couple Communication Skills Training for Advanced Cancer 5R01CA229425-05
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07
Varmus, Harold E.

Weill Medical Coll Of Cornell Univ
United States

Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells 5U01CA224326-05 Eva Szabo, M.D.
Yaddanapudi, Kavitha

University Of Louisville
United States

A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer 5R21CA277314-02 PAR-20-292 (R21 Clinical Trial Optional)
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Digiovanni, John

University Of Texas At Austin
United States

Identification of Natural Compound Combinations for Prevention of Prostate Cancer 5R01CA228404-05 Marjorie Perloff, M.D.
Feliciano, Elizabeth Marjorie Cespedes

Kaiser Foundation Research Institute
United States

D3-creatine dilution to determine skeletal muscle mass in colon cancer patients 5R01CA240394-04 PAR-18-893 (R01 Clinical Trial Optional) Gabriela Riscuta, M.D., C.N.S.
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Determinants of transdermal drug delivery to the normal and the radiated breast 5R01CA235647-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sorror, Mohamed

Fred Hutchinson Cancer Center
United States

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality 5R01CA227092-06
El-Bayoumy, Karam E

Pennsylvania State Univ Hershey Med Ctr
United States

Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies 5R01CA173465-10
Herrmann, Joerg

Mayo Clinic Rochester
United States

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial 5R01CA233610-06 PA-18-003 (R01 Clinical Trial Optional)
Mehta, Anand S

Medical University Of South Carolina
United States

Glycopathology of HCC: identification of the source cells of serum fucosylation 5U01CA226052-05 PAR-17-206 (U01)
Drake, Richard R.

Medical University Of South Carolina
United States

Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids 5R33CA267226-03 RFA-CA-21-004 (R33 Clinical Trial Not Allowed)
Hunter, Jessica Ezzell

Kaiser Foundation Research Institute
United States

Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer 5U01CA244323-04
Sowers, Lawrence C

University Of Texas Med Br Galveston
United States

Cytosine Deamination Adducts and Cancer Etiology 5R01CA228085-05
Bae-Jump, Victoria Lin

Univ Of North Carolina Chapel Hill
United States

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer 5R37CA226969-07
Dashwood, Roderick H

Texas A&M University Health Science Ctr
United States

CCAR2 as a Target for Prevention of Colorectal Cancer. 5R01CA122959-11
Esserman, Laura J

University Of California, San Francisco
United States

Extending the Diversity, Reach, and Generalizability of the WISDOM Study 5R01CA237533-05
Furuta, Saori

Case Western Reserve University
United States

Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer 5R01CA248304-05
Zhang, Fan

University Of Florida
United States

R21 MPI microRNA directed therapy for treating early stage pancreatic cancer 5R21CA277263-02
Thompson, Patricia Ann

State University New York Stony Brook
United States

Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk 5R01CA235720-05
Nath, Kavindra

University Of Pennsylvania
United States

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition 5R01CA228457-05
Kinney, Anita Y.

American Society Of Preventive Oncology, Inc.
United States

2024 Annual Conference Grant: American Society of Preventive Oncology 1R13CA290995-01 Wendy Wang, Ph.D., M.Sc.
Robertson, Gavin P.

Pennsylvania State Univ Hershey Med Ctr
United States

Targeting Aldehyde Dehydrogenase for Cancer Prevention 5R01CA241148-04
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-02 PAR-19-264 (R01 Clinical Trial Optional)
Mallick, Parag Kumar

Stanford University
United States

Pathomic Predictors of Prostate Cancer Progression 5R01CA249899-04 PAR-19-264 (R01 Clinical Trial Optional)
Vigneron, Daniel B

University Of California, San Francisco
United States

Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients 5U01CA232320-05 PAR-16-089 (U01)
Kisiel, John

Mayo Clinic Rochester
United States

Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation 4R37CA214679-06
Haab, Brian B.

Van Andel Research Institute
United States

Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers 5U01CA226158-05 PAR-17-206 (U01)
Schedin, Pepper J

Oregon Health & Science University
United States

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention 5R01CA169175-10
Shen, Qiang

Lsu Health Sciences Center
United States

Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 5R01CA226001-06
Singh, Shivendra

University Of Pittsburgh At Pittsburgh
United States

The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180 5R01CA219180-05
Li, Hongjin

University Of Illinois At Chicago
United States

A Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors 1R21CA277153-01A1 Goli Samimi, Ph.D., M.P.H.
Nelson, Randy J.

West Virginia University
United States

Mechanism Underlying Sleep Disruption by Mammary Tumors 1R21CA276027-01A1 Marge Good, R.N., M.P.H., O.C.N.
Chen, Grace Y.

University Of Michigan At Ann Arbor
United States

Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention 1R21CA273646-01A1 Winfred Malone, Ph.D., M.P.H.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-04
Eibl, Guido Erwin Michael

University Of California Los Angeles
United States

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma 5P01CA236585-04 PAR-18-290 (P01 Clinical Trial Optional)
Hansen, Laura A

Creighton University
United States

Targeting aberrant anti-apoptotic signaling for prevention of skin cancer 5R01CA253573-04
Bride, Colleen M Mc

Emory University
United States

Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services 5U01CA240581-04 PAR-18-616 (U01 Clinical Trial Optional)
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation 3R01CA238423-04S1
Rozengurt, Juan Enrique

University Of California Los Angeles
United States

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression 5R21CA258125-02
Frazier, A Lindsay

Dana-Farber Cancer Inst
United States

Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-04
Kelleher, Sarah

Duke University
United States

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings 1R21CA273832-01A1
Pitteri, Sharon

Stanford University
United States

Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-05
Richards-Kortum, Rebecca R.

Rice University
United States

Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer 5R01CA251911-04
Sehgal, Ashwini

Case Western Reserve University
United States

Pain and Immobility After Breast Cancer Surgery: A Community-Based Randomized Controlled Trial of Myofascial Massage Treatment 5R01CA229287-04 Goli Samimi, Ph.D., M.P.H.
Grace, Peter M

University Of Tx Md Anderson Can Ctr
United States

PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain 5R01CA227064-06
Azizoddin, Desiree R

University Of Oklahoma Hlth Sciences Ctr
United States

Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain 5R21CA263838-02
Borges, Chad R

Arizona State University-Tempe Campus
United States

Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions 5R21CA269091-02 RFA-CA-21-005 (R21 Clinical Trial Not Allowed)
Schloss, Patrick David

University Of Michigan At Ann Arbor
United States

muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer 5U01CA264071-02 RFA-CA-21-014 (U01 Clinical Trial Optional)
Chapkin, Robert Stephen

Texas A&M Agrilife Research
United States

Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling 5R01CA244359-04
Phd, Ralph Weissleder, Md,

Massachusetts General Hospital
United States

Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) 5R01CA237332-04 PAR-16-276 (R01)
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-05
Radisky, Derek C

Mayo Clinic Jacksonville
United States

Involution-based biomarkers of breast cancer risk 3R01CA237602-04S1
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms 5R01CA247220-04
Hruska, Carrie B

Mayo Clinic Rochester
United States

Density MATTERS Clinical Trial 5R01CA239200-04
Rogers, Laura Q

University Of Alabama At Birmingham
United States

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-05 Gabriela Riscuta, M.D., C.N.S.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 1R21CA274021-01A1 Guillermo Marquez, Ph.D.
Chibwesha, Carla J

Univ Of North Carolina Chapel Hill
United States

Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV 5R01CA250850-04
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-04
Thakur, Mathew Laxman

Thomas Jefferson University
United States

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-04
Johnson, Constance Margaret

University Of Texas Hlth Sci Ctr Houston
United States

The relationship between fMRI and patient-reported outcomes in chemotherapy-induced neuropathy:  A diversity supplement 3R01CA245054-04S1
Simone, Donald

University Of Minnesota
United States

Neural Mechanisms of Cancer Pain 5R01CA241627-05
Mao, Jun J

Sloan-Kettering Inst Can Research
United States

Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) 5R01CA240417-04
Iyer, Prasad G.

Mayo Clinic Rochester
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 5R01CA241164-05
Svatek, Robert Scott

University Of Texas Hlth Science Center
United States

eRapa for bladder cancer prevention 5R01CA252057-04 PAR-19-183 (R01 Clinical Trial Optional)
Sant, Shilpa

University Of Illinois At Chicago
United States

Three-dimensional organoid models to study breast cancer progression 4R37CA232209-06
Hartman, Terryl J.

Emory University
United States

Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer 5R01CA245063-04
Goggins, Michael G.

Johns Hopkins University
United States

Using Markers to Improve Pancreatic Cancer Screening 5R01CA176828-09
Linnes, Jacqueline

Purdue University
United States

Point-of-care screening test for early cervical cancer detection 5R01CA246315-04
Brenner, Dean E.

University Of Michigan At Ann Arbor
United States

Early Phase Clinical Cancer Prevention Consortium 5UG1CA242632-04 RFA-CA-19-031 (UG1 Clinical Trial Required) Donald Johnsey
Cao, Yin

Washington University
United States

Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 5R37CA246175-04
Mallery, Susan R

Ohio State University
United States

Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions 5R01CA227273-05
Li, Feng

University Of California Los Angeles
United States

Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. 1R21CA283665-01
Alambeigi, Farshid

University Of Texas At Austin
United States

A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps 1R21CA280747-01A1 Matthew Young, Ph.D.
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 1R21CA277464-01A1 Sharon Ross, Ph.D., M.P.H.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Carter, Bob S

Massachusetts General Hospital
United States

Standardized Molecular Analyses of Glioma EVs 5R01CA237500-04
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Winters-Stone, Kerri M

Oregon Health & Science University
United States

Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer 5R01CA248059-04 Goli Samimi, Ph.D., M.P.H.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Forsberg, Flemming

Thomas Jefferson University
United States

Prostate Cancer Diagnosis by Multiparametric Ultrasound 5R01CA252311-04
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Zheng, Yingye

Fred Hutchinson Cancer Center
United States

Statistical Methods for Prospective Evaluation of Biomarkers 5R01CA236558-14 Nick Hodges, Ph.D.
Sieren, Jessica C

University Of Iowa
United States

Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers 5R01CA267820-02 Nick Hodges, Ph.D.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-10
Chung, Ki Young

Prisma Health - Upstate
United States

NCORP of the Carolinas (Greenville Health System NCORP) 6UG1CA189972-10
Lad, Thomas

Hektoen Institute For Medical Research
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal 5UG1CA190000-10
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 5UG1CA189821-10
Rowland, Kendrith Martin

Carle Foundation
United States

Carle Cancer Center NCI Community Oncology Research Program (NCORP) 5UG1CA189861-10
Caywood, Emi H

Alfred I. Du Pont Hosp For Children
United States

Nemours NCI Community Oncology Research Program (NCORP) 5UG1CA189958-10
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 5UG1CA190140-10
Halmos, Balazs

Montefiore Medical Center (Bronx, Ny)
United States

MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM 5UG1CA189859-10
Paskett, Electra D.

Alliance Nctn Foundation
United States

Alliance NCORP Research Base - BIQSFP GY10 Supplements 3UG1CA189823-10S1
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 5UG1CA189957-10
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP MU 5UG1CA189855-10
Chow, H-H. Sherry

University Of Arizona
United States

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) 5UG1CA242596-05 RFA-CA-18-029 (UG1 Clinical Trial Required) Donald Johnsey
Lesser, Glenn J

Wake Forest University Health Sciences
United States

Wake Forest NCORP Research Base 5UG1CA189824-10
Curtis, Amarinthia E

Spartanburg Regional Medical Center
United States

Upstate Carolina Consortium - Community Oncology Research Program 5UG1CA239762-05
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 5UG1CA189971-10
Milanovich, Samuel J

Sanford Research/Usd
United States

Sanford Community Cancer Program of the North Central Plains (NCORP) 5UG1CA189825-10
Pollock, Brad H

Public Health Institute
United States

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant 3UG1CA189955-10S2
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 5UG1CA189872-10
Remick, Scot C

Mainehealth
United States

MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan 5UG1CA239771-05
Yost, Kathleen J

Spectrum Health Hospitals
United States

Cancer Research Consortium of West Michigan (CRCWM) 5UG1CA189860-10
Santos-Reyes, Luis Javier

Comprehensive Cancer Center/ Univ/Pr
United States

Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP) 5UG1CA189862-10
Vinciguerra, Vincent P

Feinstein Institute For Medical Research
United States

Northwell Health NCORP 5UG1CA189850-10
Bruner, Deborah Watkins

Nrg Oncology Foundation, Inc.
United States

NRG Oncology NCORP Research Base 5UG1CA189867-10
Blanke, Charles D.

Oregon Health & Science University
United States

Cancer Disparity Collaborative Supplement: Integrating electronic health record and patient-generated health data for breast cancer and cardiovascular disease risk assessment among diverse multiet... 3UG1CA189974-10S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cantuaria, Guilherme

Northside Hospital Atlanta
United States

Georgia NCI Community Oncology Research Program (GA NCORP) 5UG1CA189997-10
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 5UG1CA189822-10
Berenberg, Jeffrey Lee

University Of Hawaii At Manoa
United States

The Hawaii Minority/Underserved NCORP 5UG1CA189804-10
Ellerton, John A

Southern Nevada Cancer Research Fdn
United States

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) 5UG1CA189829-10
Faller, Bryan

Decatur Memorial Hospital
United States

Heartland Cancer Research NCORP 5UG1CA189830-10
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 5UG1CA189812-10
Drescher, Charles

Swedish Medical Center, First Hill
United States

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site 5UG1CA189953-10
Md, Nicholas Dibella

Western States Cancer Research Ncorp
United States

Western States Cancer Research NCORP 5UG1CA189805-10
Matin, Khalid

Virginia Commonwealth University
United States

VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program 5UG1CA189869-10
Doolittle, Gary C.

University Of Kansas Medical Center
United States

The University of Kansas Cancer Center's- MCA Rural NCORP 5UG1CA239767-05
Williams, Paige L

Harvard School Of Public Health
United States

Pediatric HIV/AIDS Cohort Study (PHACS) 2020 5P01HD103133-04
Onitilo, Adedayo A

Marshfield Clinic Research Foundation
United States

Wisconsin NCI Community Oncology Research Program (WiNCORP) 5UG1CA189956-10
Kachnic, Lisa A.

Columbia University Health Sciences
United States

Columbia University Minority/Underserved Site NCI Community Oncology Research Program 5UG1CA189960-10
Salman, Emad

Florida Assn Of Pediatric Tumor Prog
United States

The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program. 5UG1CA189973-10
Ghamande, Sharad A.

Augusta University
United States

Georgia CaRes 5UG1CA189851-10
Panikkar, Rajiv

Geisinger Clinic
United States

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) 5UG1CA189847-10
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites 5UG1CA189856-10
Irvin, William J

Southeast Clinical Oncol Res Consortium
United States

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) 5UG1CA189858-10
Masters, Gregory A

Christiana Care Health Services, Inc.
United States

Delaware Christiana Care NCORP 5UG1CA189819-10
Whitman, Eric

Atlantic Health System, Inc.
United States

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP) 5UG1CA239772-05
Adams-Campbell, Lucile Lauren

Georgetown University
United States

National Capital Area (NCA) Minority/Underserved NCORP 5UG1CA239758-05
Osarogiagbon, Raymond U

Baptist Memorial Hospital - Tipton
United States

Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium 5UG1CA189873-10
Jaslowski, Anthony J

St. Vincent Hospital
United States

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium 5UG1CA239769-05
Anderson, Daniel M

Healthpartners Institute
United States

Metro-Minnesota Community Oncology Research Consortium (MMCORC) 5UG1CA189863-11
Bailey, Lisa (Nmn)

Bay Area Tumor Institute
United States

Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites 5UG1CA189817-10
Marshall, David T.

Medical University Of South Carolina
United States

Medical University of South Carolina NCORP Minority/Underserved Community Site 5UG1CA189848-10
Siddique, Shahzad

Commonspirit Health Research Institute
United States

CIRI Oncology Research Alliance 5UG1CA189809-10
Lukenbill, Joshua Cole

Iowa Oncology Research Association
United States

Iowa-Wide Oncology Research Coalition (I-WORC) 5UG1CA189816-10
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Northwestern Cancer Prevention Consortium 5UG1CA242643-05 RFA-CA-18-029 (UG1 Clinical Trial Required) Donald Johnsey
Wagner, Lynne I.

Ecog-Acrin Medical Research Foundation
United States

ECOG-ACRIN NCORP Research Base - TMIST 3UG1CA189828-10S1
Moore, Timothy David

Columbus Community Clinical Oncology Prg
United States

Columbus NCORP RFA-CA-18-016 5UG1CA189954-10
Paus, Ralf

University Of Miami School Of Medicine
United States

Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia 1R21CA277418-01A1 Rachel Altshuler, Ph.D.
Wilkin, Timothy J

Weill Medical Coll Of Cornell Univ
United States

Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico 5U54CA242639-05
Palefsky, Joel Michael

University Of California, San Francisco
United States

California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations 3U54CA242646-05S1
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 5U54CA242977-06
Vilar-Sanchez, Eduardo

University Of Tx Md Anderson Can Ctr
United States

iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium 5UG1CA242609-05 Donald Johnsey
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

The MW Cancer Prevention Clinical Trials Network 5UG1CA242635-04 Donald Johnsey
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Early detection of colorectal cancer in the traditional and serrated pathways 5R01CA249851-04 PAR-19-264 (R01 Clinical Trial Optional)
Sariol, Carlos A

University Of Puerto Rico Med Sciences
United States

SARS-CoV-2 correlates of protection in a Latino-origin population 3U01CA260541-02S1 Guillermo Marquez, Ph.D.
Ahn, Jiyoung

New York University School Of Medicine
United States

The Oral Mycobiome and Risk of Pancreatic Cancer 5U01CA250186-03 PAR-18-913 (U01 Clinical Trial Not Allowed)
Hundley, William Gregory

Wake Forest University Health Sciences
United States

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-04
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-02
Elias, Kevin

Brigham And Women'S Hospital
United States

Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness 1R03CA283252-01 Christos Patriotis, Ph.D., M.Sc.
Shuck, Sarah C.

Beckman Research Institute/City Of Hope
United States

Identification of metabolic adducts associated with prostate cancer progression in African American men 1R21CA282612-01 Guillermo Marquez, Ph.D.
Counter, Christopher M

Duke University
United States

Adapting K-MDS to detect KRAS-mutant ctDNA 5R21CA257816-02
Li, Chi

University Of Louisville
United States

A lung cancer vaccine based on exosomes of induced pluripotent stem cells 1R21CA280453-01 John Clifford, Ph.D.
Wang, Jing

New York University School Of Medicine
United States

Optimizing the use of ketamine to reduce chronic postsurgical pain 5UH3CA261067-04
Albertson, Donna G

New York University
United States

Artemin overexpression in oral cancer pain and carcinogenesis 5R01CA228525-05
Wilson, Michael R

Wayne State University
United States

Does obesity influence protein quality control in endometrial cancer? 5R00CA252152-04
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 7R37CA248563-04
Elenitoba-Johnson, Kojo S. J.

Sloan-Kettering Inst Can Research
United States

Genomic biomarkers of splenic lymphoma 5R01CA255655-05
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-05
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 1R21CA279916-01A1
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-10
Fitzgibbon, Marian L

University Of Illinois At Chicago
United States

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk 5R01CA250390-04
Fuschiotti, Patrizia

University Of Pittsburgh At Pittsburgh
United States

Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 1R21CA280445-01A1 Wendy Wang, Ph.D., M.Sc.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 1R21CA280230-01A1 Eileen Dimond, R.N., M.S.
Tollefsbol, Trygve O

University Of Alabama At Birmingham
United States

Combinatorial epigenetic-based prevention of breast cancer 5R01CA178441-09
Zhu, Yazhen

University Of California Los Angeles
United States

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma 5R01CA255727-04
Maldonado, Fabien

Vanderbilt University Medical Center
United States

Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures 5R01CA253923-04
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 5R01CA258231-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Palesh, Oxana G

Virginia Commonwealth University
United States

Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia 5R01CA239714-06
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer 5R01CA254036-04
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-04
Xiao, Yi

University Of Tx Md Anderson Can Ctr
United States

Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1 1R21CA286318-01 Anda Vlad, M.D., Ph.D.
Barber, Glen N.

University Of Miami School Of Medicine
United States

Development of A HTLV-1 Vaccine 5R01CA252049-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Nolan, Michael Warren

North Carolina State University Raleigh
United States

Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer 5R37CA248797-04
Deng, Gary E

Sloan-Kettering Inst Can Research
United States

Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial 1R21CA286330-01 Goli Samimi, Ph.D., M.P.H.
Terry, Kathryn L

Brigham And Women'S Hospital
United States

Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Godwin, Andrew K.

University Of Kansas Medical Center
United States

Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 3R01CA260132-03S1
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 7R01CA251470-04
Kroetz, Deanna L

Ohio State University
United States

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity 7R01CA261068-04
Chan, Andrew T

Massachusetts General Hospital
United States

Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. 5R01CA257523-03
Schmidt, Christian Maximillian

Indiana Univ-Purdue Univ At Indianapolis
United States

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-03 PAR-18-913 (U01 Clinical Trial Not Allowed)
Dhakal, Soma

Virginia Commonwealth University
United States

Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers 1R61CA278445-01 Christos Patriotis, Ph.D., M.Sc.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-03
Shalon, Tidhar Dari

Envivo Bio Inc
United States

Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring 4R33CA260665-02 Sharon Ross, Ph.D., M.P.H.
Jiang, Feng

University Of Maryland Baltimore
United States

Plasma biomarkers for lung cancer diagnosis 4UH3CA251139-03
Tayob, Nabihah

Dana-Farber Cancer Inst
United States

Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma 5R01CA230503-05 Nick Hodges, Ph.D.
Rosenberg, Daniel William

University Of Connecticut Sch Of Med/Dnt
United States

Microbiota, Metabolites, and Colon Neoplasia 5R01CA252045-03 PA-18-902 (R01 Clinical Trial Optional)
Livneh, Zvi

Weizmann Institute Of Science
United States

Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort 1U01CA279001-01 Claire Zhu, Ph.D.
Liu, Yang

University Of Pittsburgh At Pittsburgh
United States

Imaging nanoscale chromatin folding in early carcinogenesis 5R01CA254112-04
Carson, Tiffany Lashaun

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults 5R01CA253219-04
Bertozzi, Carolyn

Stanford University
United States

Chemical Glycoproteomics 5R01CA200423-20 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Boyer, Thomas G

University Of Texas Hlth Science Center
United States

Pathological reprogramming of the m6A epitranscriptome in uterine fibroids 5R01HD106285-03
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hanks, Brent Allen

Duke University
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 5R01CA251136-03 PAR-19-325 (R01 Clinical Trial Optional) Marjorie Perloff, M.D.
Kong, Mei

University Of California-Irvine
United States

Using dietary glutamine supplementation for melanoma prevention and targeted therapy 5R01CA244360-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hitchins, Megan P

Cedars-Sinai Medical Center
United States

Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age 5R01CA252042-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Lubman, David M

University Of Michigan At Ann Arbor
United States

Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach 5R01CA160254-12
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 5R37CA273959-02
Djuric, Zora

University Of Michigan At Ann Arbor
United States

MyGI Diet for Colorectal Cancer Prevention 5R01CA255743-03
Cohn, Barbara A

Public Health Institute
United States

Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer 5R01CA264519-03
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 3R01CA258311-03S1
Yendamuri, Saikrishna

Roswell Park Cancer Institute Corp
United States

Metformin for chemoprevention of lung cancer in obese subjects at high risk 3R01CA255515-03S1
Hur, Chin

Columbia University Health Sciences
United States

Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 5R01CA257333-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Khasabov, Sergey G

University Of Minnesota
United States

Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling 5R01CA263777-03
Fabian, Carol J

University Of Kansas Medical Center
United States

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer 5R01CA249437-03 Edward Sauter, M.D., Ph.D.
Sigel, Keith Magnus

Icahn School Of Medicine At Mount Sinai
United States

The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors 5R01CA256660-03
Metzger, Gregory John

University Of Minnesota
United States

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 5R01CA241159-03
Marchand, Loic Le

University Of Hawaii At Manoa
United States

Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial 5R01CA258179-03 RFA-CA-20-004 (R01 Clinical Trial Optional)
Ondrey, Frank G.

University Of Minnesota
United States

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia 5R01CA254270-02 PAR-21-035 (R01 Clinical Trial Required)
Panda, Satchidananda

Salk Institute For Biological Studies
United States

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function 3R01CA258221-03S1 RFA-CA-20-004 (R01 Clinical Trial Optional)
Schmit, Stephanie L

Cleveland Clinic Lerner Com-Cwru
United States

Variation in tumor-associated immune profiles and colorectal cancer outcomes 5R01CA248931-03
Hecht, Stephen S

University Of Minnesota
United States

High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck 5R01CA263084-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Ulrich, Cornelia M

University Of Utah
United States

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link 5R01CA254108-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Tussing-Humphreys, Lisa

University Of Illinois At Chicago
United States

Mediating Role of Gut Microbiota in the Regulation of Colorectal Cancer Risk in the Context of Time-restricted Eating and Calorie Restriction 3R01CA257807-03S1 RFA-CA-20-004 (R01 Clinical Trial Optional)
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls 5U01CA260758-03 PAR-18-913 (U01 Clinical Trial Not Allowed)
Li, Debiao

Cedars-Sinai Medical Center
United States

Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images 5R01CA260955-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Park, Youngkyu

Cold Spring Harbor Laboratory
United States

Preclinical Models for Cancer Therapeutic Development 5R50CA211506-08
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 1R33CA281802-01
Vilar-Sanchez, Eduardo

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception for Lynch Syndrome 5R01CA257375-03
Mungo, Chemtai Chemtai

Univ Of North Carolina Chapel Hill
United States

Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs 1R34CA284983-01 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Zarrinpar, Amir

University Of California, San Diego
United States

Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-03
Kahalley, Lisa Schum

Baylor College Of Medicine
United States

Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. 3R01CA249988-03S1
Yang, Wan

Columbia University Health Sciences
United States

UNCOVER: underlying novel causes of onset of very early cancer research 5R01CA257971-03 Nick Hodges, Ph.D.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1
Peppone, Luke Joseph

University Of Rochester
United States

High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients 5R01CA258349-03 PAR-21-035 (R01 Clinical Trial Required)
Sempere, Lorenzo

Michigan State University
United States

Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer 5R01CA258314-03 Edward Sauter, M.D., Ph.D.
Goncalves, Marcus Dasilva

Weill Medical Coll Of Cornell Univ
United States

Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival 5R01CA258697-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-03 PAR-19-325 (R01 Clinical Trial Optional)
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-03 PAR-20-053 (R01 Clinical Trial Not Allowed)
Shureiqi, Imad

University Of Michigan At Ann Arbor
United States

ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism 5R01CA266223-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-02 Guillermo Marquez, Ph.D.
Nicolson, Fay

Dana-Farber Cancer Inst
United States

SESORRS endoscopy for the staging and evaluation of colorectal cancer 4R00CA266921-03 Gary Della'Zanna, D.O., M.Sc.
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-03
Barton, Jennifer Kehlet

University Of Arizona
United States

Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers 3R01CA260399-03S1
Stolley, Melinda R

Medical College Of Wisconsin
United States

Every Day Counts: A lifestyle program for women metastatic breast cancer 5R01CA258759-03 PAR-18-893 (R01 Clinical Trial Optional)
Sherman, Mark E

Mayo Clinic Jacksonville
United States

Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) 5R01CA262393-03
Beretta, Laura

University Of Tx Md Anderson Can Ctr
United States

Early Detection of Hepatocellular Carcinoma 5R01CA195524-08 PAR-19-264 (R01 Clinical Trial Optional)
Cremer, Miriam

Cleveland Clinic Lerner Com-Cwru
United States

Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador 3R01CA266059-02S1
Huberty, Jennifer Lynne

University Of Texas Hlth Science Center
United States

Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients 5R01CA262041-03
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-02S1 PA-18-917 (R01 - Clinical Trial Optional) Sharon Ross, Ph.D., M.P.H.
Liu, Changchun

University Of Connecticut Sch Of Med/Dnt
United States

Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care 5U01CA269147-02
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis 5R01CA262551-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules 5R01CA252964-03
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-03
Wallace, Douglas C

Children'S Hosp Of Philadelphia
United States

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA 5R01CA259635-02 PAR-19-198 (R01 Clinical Trial Not Allowed)
Ramanujam, Nirmala

Duke University
United States

Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening 5U01CA269192-02
Kolb, Noah Allan

University Of Vermont & St Agric College
United States

Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy 5R01CA247517-03
Mallery, Susan R

Ohio State University
United States

Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention 5R01CA258757-02 PAR-21-035 (R01 Clinical Trial Required) Malgorzata (Margaret) Wojtowicz, M.D.
Rini, Christine

Northwestern University At Chicago
United States

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial 5R01CA271220-02 PAR-21-035 (R01 Clinical Trial Required)
Ameringer, Suzanne W

Virginia Commonwealth University
United States

A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer 1R01CA286799-01 Ellen Richmond, M.S., G.N.P.-B.C.
Malafa, Mokenge P

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Novel Therapy to Inhibit IPMN Progression 5R01CA263575-02
Smith, Jennifer Susan

Univ Of North Carolina Chapel Hill
United States

UNC CASCADE Network Research Base 5UG1CA275403-02 Silvina Frech, Ph.D., M.S.
Siminski, Suzanne M.

Frontier Sci & Technology Rsch Fdn, Inc
United States

CASCADE Coordinating Center 5U24CA275417-02 Silvina Frech, Ph.D., M.S.
Winer, Rachel L.

University Of Washington
United States

The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base 5UG1CA275402-02 Silvina Frech, Ph.D., M.S.
Adebamowo, Clement Adebayo

University Of Maryland Baltimore
United States

Baltimore CASCADE Study Site (BaCSS Project) 1UG1CA284883-01 Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.

Emory University
United States

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) 1UG1CA284884-01 Silvina Frech, Ph.D., M.S.
Chung, Michael Hoonbae

Emory University
United States

HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) 5UG1CA275400-02 Silvina Frech, Ph.D., M.S.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

CAPRISA CASCADE Clinical Trials Network Clinical Research Site 1UG1CA284671-01 Silvina Frech, Ph.D., M.S.
Wilkin, Timothy J

Weill Medical Coll Of Cornell Univ
United States

Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) 5UG1CA275414-02 Silvina Frech, Ph.D., M.S.
Chirenje, Zvavahera Mike

University Of California, San Francisco
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) 1UG1CA284918-01 Silvina Frech, Ph.D., M.S.
Mugo, Nelly Rwamba

Kenya Medical Research Institute (Kemri)
United States

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH 1UG1CA285132-01 Silvina Frech, Ph.D., M.S.
Mwesigwa, Betty

Makerere University Walter Reed Project
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) 5UG1CA275412-02 Silvina Frech, Ph.D., M.S.
Murenzi, Gad

Research For Development
United States

Rwanda CASCADE Clinical Trials Site for cervical cancer prevention 1UG1CA284908-01 Silvina Frech, Ph.D., M.S.
Dryden-Peterson, Scott Lee

Brigham And Women'S Hospital
United States

Botswana CASCADE Clinical Trials Site 5UG1CA275416-02 Silvina Frech, Ph.D., M.S.
Caulin, Carlos

University Of Arizona
United States

Genetic Alterations That Confer High Risk to Oral Premalignant Lesions 5R01CA274857-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Liang, Han

University Of Tx Md Anderson Can Ctr
United States

The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data 5U24CA264128-02 RFA-CA-21-015 (U24 Clinical Trial Optional)
Huang, Ying

Western University Of Health Sciences
United States

Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hawkins, Shannon Michelle

Indiana Univ-Purdue Univ At Indianapolis
United States

Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas 5R01HD109707-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Valdimarsdottir, Heiddis

Icahn School Of Medicine At Mount Sinai
United States

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-02 PAR-21-035 (R01 Clinical Trial Required)
El-Serag, Hashem B

Baylor College Of Medicine
United States

Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome 5P01CA263025-02
Sidransky, David

Johns Hopkins University
United States

Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 5R01CA265975-02
Ross, Stephen

New York University School Of Medicine
United States

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-02
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-02
Feng, Ziding

Fred Hutchinson Cancer Center
United States

The Early Detection Research Network: Data Management and Coordinating Center 5U24CA086368-23 RFA-CA-21-034 (U24 Clinical Trial Not Allowed)
Vilar-Sanchez, Eduardo

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Sohl, Stephanie Jean

Wake Forest University Health Sciences
United States

REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) 5R01CA266995-02 PAR-21-035 (R01 Clinical Trial Required) Goli Samimi, Ph.D., M.P.H.
Hebert, James R

University Of South Carolina At Columbia
United States

A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer 5U01CA272977-02
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-02 Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus 5U2CCA271902-02 Matthew Young, Ph.D.
Lenburg, Marc Elliott

Boston University Medical Campus
United States

The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-02
Sun, Ju

University Of Minnesota
United States

SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data 1R01CA287413-01 Amanda Skarlupka, Ph.D.
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-02
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 5U01CA271887-02
Chinnaiyan, Arul M

University Of Michigan At Ann Arbor
United States

Michigan-VUMC Biomarker Characterization Center 5U2CCA271854-02
Li, Christopher I

Fred Hutchinson Cancer Center
United States

Fred Hutchinson Breast Cancer Clinical Validation Center 5U01CA152637-13
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-07 PAR-21-334 (U01 Clinical Trial Optional)
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 5R01CA196853-07 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Infante, Rodney E

Ut Southwestern Medical Center
United States

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 5R01CA266900-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Markowitz, Sanford D.

Case Western Reserve University
United States

Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation 5U01CA271867-02 RFA-CA-21-033 (U01 Clinical Trial Optional)
Wolpin, Brian Matthew

Dana-Farber Cancer Inst
United States

Altered metabolism and machine learning for pancreatic cancer early detection 5U01CA210171-07 PAR-21-334 (U01 Clinical Trial Optional)
Lin, Jia-Ren

Harvard Medical School
United States

Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 5R50CA274277-02
Oberg, Ann Laura

Mayo Clinic Rochester
United States

Management and Data Coordination Unit for PCDC 5U24CA274496-02 PAR-21-335 (U24 Clinical Trial Not Allowed)
Cheng, Leo L

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 5R01CA273010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hanash, Samir M

University Of Tx Md Anderson Can Ctr
United States

Clinical Validation Center for Lung Cancer Early Detection 5U01CA271888-02 RFA-CA-21-033 (U01 Clinical Trial Optional)
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-02 RFA-CA-21-033 (U01 Clinical Trial Optional)
Robbins, Hilary A.

International Agency For Res On Cancer
United States

The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening 5R01CA262164-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Molecular prediction of myeloma in African Americans 5U01CA271492-02 PAR-18-913 (U01 Clinical Trial Not Allowed)
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care 5R01CA261874-02
Zhao, Hua

University Of Virginia
United States

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor 7U01CA260731-02 PAR-18-913 (U01 Clinical Trial Not Allowed)
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 5R01CA259019-02 PAR-20-155 (R01 Clinical Trial Optional)
Chung, Raymond T

Massachusetts General Hospital
United States

Trial of Statins for Chemoprevention in Hepatocellular Carcinoma 5R01CA255621-03
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer 5U01CA152662-12 RFA-CA-21-033 (U01 Clinical Trial Optional)
Chan, Andrew T

Massachusetts General Hospital
United States

Precision Prevention Research Program 5R35CA253185-04 PAR-19-349 (R35 Clinical Trial Not Allowed)
Carlsson, Sigrid

Sloan-Kettering Inst Can Research
United States

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers 5U01CA266535-02 PAR-18-913 (U01 Clinical Trial Not Allowed)
Grimm, Lars J

Duke University
United States

Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications 5R01CA271237-02 PAR-19-264 (R01 Clinical Trial Optional)
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-02 RFA-CA-21-055 (U24 Clinical Trial Not Allowed)
Goggins, Michael G.

Johns Hopkins University
United States

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-07 PAR-21-334 (U01 Clinical Trial Optional)
Hollingsworth, Michael A.

University Of Nebraska Medical Center
United States

Pancreatic Cancer Detection Consortium 5U01CA210240-07 PAR-21-334 (U01 Clinical Trial Optional)
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

Detecting and locating cancer for patients with CT-detected lung nodules 5R01CA264864-02 PAR-19-264 (R01 Clinical Trial Optional)
Rosenbluth, Jennifer M

University Of California, San Francisco
United States

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer 5R01CA281361-02
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center 5U54CA272686-02 RFA-CA-21-038 (U54 Clinical Trial Not Allowed)
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

CAP-IT Center for LNP RNA Immunoprevention 5U54CA272688-02 RFA-CA-21-038 (U54 Clinical Trial Not Allowed)
Wu, Yun

State University Of New York At Buffalo
United States

Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay 5R01CA272827-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Plas, Ellen Van Der

Arkansas Children'S Hospital Res Inst
United States

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia 5R37CA266135-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 5R01CA260901-02 PAR-21-035 (R01 Clinical Trial Required)
Maitra, Anirban

University Of Tx Md Anderson Can Ctr
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 5U01CA200468-07
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

High-resolution mutational landscape of the primed colon in early onset colorectal cancer 3U54CA274374-02S1
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis 1U01CA288375-01
Herman, James G.

University Of Pittsburgh At Pittsburgh
United States

Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies 5U2CCA271885-02 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-02 Christos Patriotis, Ph.D., M.Sc.
Skates, Steven J

Massachusetts General Hospital
United States

Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer 5U2CCA271871-02 Christos Patriotis, Ph.D., M.Sc.
Slager, Susan L

Mayo Clinic Rochester
United States

The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) 5R01CA258465-02
Cheville, Andrea Lynne

Mayo Clinic Rochester
United States

Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial 4R33CA278594-02 Brennan Streck, Ph.D., R.N., M.P.H.
Im, Eun-Ok

University Of Texas At Austin
United States

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors 4R33CA280979-02 Brennan Streck, Ph.D., R.N., M.P.H.
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-02 Guillermo Marquez, Ph.D.
Li, Yong

Baylor College Of Medicine
United States

Cancer Prevention-Interception Against MGUS Progression 1U54CA272691-01A1 Vignesh Gunasekharan, Ph.D.
Semmes, Oliver John

Eastern Virginia Medical School
United States

Virginia-UCLA-Toronto Biomarker Characterization Center 5U2CCA271894-02 Indu Kohaar, Ph.D.
Cocucci, Emanuele

Ohio State University
United States

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL 5R01CA270251-02 PAR-20-053 (R01 Clinical Trial Not Allowed)
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 5R37CA269649-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-02 Nick Hodges, Ph.D.
Lee, Juhun

University Of Pittsburgh At Pittsburgh
United States

Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis 5R01CA269540-02
Pyter, Leah M

Ohio State University
United States

Chemotherapy-induced circadian master clock disruptions and fatigue 3R01CA270372-02S1 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-02
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-02
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 1UG1CA286954-01 Elyse LeeVan, M.D., M.P.H.
Kooperberg, Charles L

Fred Hutchinson Cancer Center
United States

Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) 1UG1CA287013-01 Elyse LeeVan, M.D., M.P.H.
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub 1UG1CA287044-01 Elyse LeeVan, M.D., M.P.H.
Krist, Alexander H

Virginia Commonwealth University
United States

Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) 1UG1CA287017-01 Elyse LeeVan, M.D., M.P.H.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study 1UG1CA287011-01 Elyse LeeVan, M.D., M.P.H.
Neslund-Dudas, Christine Marie

Henry Ford Health + Michigan State University Health Sciences
United States

HFH-MSU CSRN ACCrual Enrollment and Screening Site 1UG1CA287007-01 Elyse LeeVan, M.D., M.P.H.
Reuland, Daniel S.

Univ Of North Carolina Chapel Hill
United States

Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) 1UG1CA286949-01 Elyse LeeVan, M.D., M.P.H.
James, Aimee S

Washington University
United States

Building equity in cancer screening through research: The Siteman Catchment CSRN Hub 1UG1CA286946-01 Elyse LeeVan, M.D., M.P.H.
Cook, Linda S

University Of Colorado Denver
United States

Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) 1UG1CA286941-01 Elyse LeeVan, M.D., M.P.H.
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Ah, Diane Marie Von

Ohio State University
United States

Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial 5R01CA276222-02
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-02
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-02
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-02
Brand, Randall

University Of Pittsburgh At Pittsburgh
United States

Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma 2U01CA200466-06A1
Kibel, Adam S

Brigham And Women'S Hospital
United States

Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer 1U01CA268810-01A1 Richard Mazurchuk, Ph.D.
Dashwood, Roderick H

Texas A&M University Health Science Ctr
United States

Immunoepigenetic targeting of MHC regulators in FAP 1R01CA257559-01A1 Winfred Malone, Ph.D., M.P.H.
Boutros, Paul Christopher

University Of California Los Angeles
United States

Germline Determinants of Prostate Cancer Evolution 1R01CA270108-01A1 Guillermo Marquez, Ph.D.
Diaz, Juan Sebastian Gomez

University Of California At Davis
United States

A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids 1R01CA273253-01A1 Nick Hodges, Ph.D.
Brown, Austin L

Baylor College Of Medicine
United States

A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia 1R01CA272981-01A1
Damaj, M. Imad

Virginia Commonwealth University
United States

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms 1R01CA272147-01A1
Cohen, Lorenzo

University Of Tx Md Anderson Can Ctr
United States

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery 1R01CA272565-01A1
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 1U01CA278923-01 Matthew Young, Ph.D.
Segal, Leopoldo Nicolas

New York University School Of Medicine
United States

Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer 1U2CCA271890-01A1 Guillermo Marquez, Ph.D.
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 1R01CA281293-01 Silvina Frech, Ph.D., M.S.
Bast, Robert C

University Of Tx Md Anderson Can Ctr
United States

MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm 2U01CA200462-06A1
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial 1R37CA273923-01A1 Eileen Dimond, R.N., M.S.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 1R01CA278816-01 Matthew Young, Ph.D.
Shah, Sohrab

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 1R01CA281928-01 Christos Patriotis, Ph.D., M.Sc.
Paulovich, Amanda G

Fred Hutchinson Cancer Center
United States

Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment 1U2CCA271873-01A1 Sidney Fu, M.D.
Buczynski, Matthew Wallace

Virginia Polytechnic Inst And St Univ
United States

Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy 1R01CA284075-01 Rachel Altshuler, Ph.D.
Allen, Peter J

Duke University
United States

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas 2R01CA182076-06A1
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 2U01CA113913-16A1
Thangaraju, Muthusamy

Augusta University
United States

Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis 1R01CA275840-01A1 Winfred Malone, Ph.D., M.P.H.
Hilakivi-Clarke, Leena A.

University Of Minnesota
United States

Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota 1R01CA276775-01A1 Amit Kumar, Ph.D.
Velculescu, Victor E.

Johns Hopkins University
United States

DNA evaluation of fragments for early interception (DELFI) of Lung cancer 1U01CA271896-01A1
Chan, Daniel Wanyui

Johns Hopkins University
United States

Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions 1U01CA274514-01A1
Zhu, Yazhen

University Of California Los Angeles
United States

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles 1R01CA277530-01A1
Bhatt, Vijaya Raj

University Of Nebraska Medical Center
United States

Aging trajectories and outcomes of older adults with acute myeloid leukemia 1R37CA276928-01A1 Brennan Streck, Ph.D., R.N., M.P.H.
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 1R01CA277817-01A1 Christos Patriotis, Ph.D., M.Sc.
Castro, Cesar M

Massachusetts General Hospital
United States

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach 1U01CA279858-01 Christos Patriotis, Ph.D., M.Sc.
Punnen, Sanoj

University Of Miami School Of Medicine
United States

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 1R01CA272766-01A1 Matthew Young, Ph.D.
Freedland, Stephen Jay

Cedars-Sinai Medical Center
United States

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes 1R01CA280081-01 Sharon Ross, Ph.D., M.P.H.
Chan, Daniel Wanyui

Johns Hopkins University
United States

BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs 1U2CCA271895-01A1 Indu Kohaar, Ph.D.
Hu, Shuiying

Ohio State University
United States

Targeting neuronal transport to ameliorate vincristine neurotoxicity 1R01CA272254-01A1 Rachel Altshuler, Ph.D.
Mclouth, Laurie

University Of Kentucky
United States

Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment 1R01CA283929-01 Brennan Streck, Ph.D., R.N., M.P.H.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 2U01CA214254-06
Pinder, Leeya F

University Of Cincinnati
United States

RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) 1R37CA284033-01 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Lampe, Paul D

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 1R01CA281801-01 Richard Mazurchuk, Ph.D.
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 1R01CA285183-01 Catherine Schweppe, Ph.D.
Bryan, Angela

University Of Colorado
United States

Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC 1R01CA284860-01 Brennan Streck, Ph.D., R.N., M.P.H.
Nyamathi, Adeline M

University Of California-Irvine
United States

Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India 1R01CA285063-01 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 1R37CA283857-01 Guillermo Marquez, Ph.D.
Anderson, Karen S.

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 1U01CA281660-01 Wendy Wang, Ph.D., M.Sc.
Lindau, Stacy Tessler

University Of Chicago
United States

Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy 1R01CA281301-01A1 Marjorie Perloff, M.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 1R37CA275916-01 Claire Zhu, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosomal biomarkers for the early detection of hepatocellular carcinoma 1R01CA271443-01A1 Matthew Young, Ph.D.
Olopade, Olufunmilayo F.

University Of Chicago
United States

Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA) 1R01CA276652-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Basu, Partha

International Agency For Res On Cancer
United States

A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs 1R37CA275824-01 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 1R01CA275762-01A1 Rachel Altshuler, Ph.D.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

The UCLA Center in Early Detection of Liver Cancer 2U01CA230705-06
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 2R01CA218513-06A1 PAR-16-276 (R01)
Kanwal, Fasiha

Baylor College Of Medicine
United States

Risk Stratification for and Early Detection of Liver Cancer 2U01CA230997-06
Heine, John J

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center 2U01CA200464-06A1
Iwelunmor, Juliet

Saint Louis University
United States

Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) 1U01CA279863-01
Hill, Joshua Aiden

Fred Hutchinson Cancer Center
United States

Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy 1R01CA276040-01A1 Sharon Ross, Ph.D., M.P.H.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 1R01CA280088-01 Goli Samimi, Ph.D., M.P.H.
Fiol, Guilherme Del

University Of Utah
United States

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 1U24CA274582-01A1 Christos Patriotis, Ph.D., M.Sc.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Epigallocatechin gallate for prevention of lethal cirrhosis complications 1R01CA282178-01 Asad Umar, D.V.M., Ph.D.
Alexandrov, Ludmil B

University Of California, San Diego
United States

Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition 1U01CA290479-01 Wendy Wang, Ph.D., M.Sc.
Simeone, Diane M

New York University School Of Medicine
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 1U01CA282272-01
Ji, Hanlee P

Stanford University
United States

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification 1P01CA265772-01A1 Asad Umar, D.V.M., Ph.D.
Zheng, Yingye

Fred Hutchinson Cancer Center
United States

Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit 1U24CA288185-01 Christos Patriotis, Ph.D., M.Sc.
Ghosh, Jayashri

Temple Univ Of The Commonwealth
United States

Development of blood-based methylation biomarkers for CRC risk prediction 1R01CA281948-01 Matthew Young, Ph.D.
Flowers, Lisa C.

Emory University
United States

Screening strategies and social determinants of health among people with high risk of anal cancer 1R01CA285198-01 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Fahrmann, Johannes F

University Of Tx Md Anderson Can Ctr
United States

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 1U01CA282216-01 Claire Zhu, Ph.D.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

Multi-cancer early detection using cell-free DNA methylome analysis 1U01CA285010-01
Chak, Amitabh

Case Western Reserve University
United States

Pathways of Injury and Repair in Barrett's Carcinogenesis 1P01CA269019-01A1 Ellen Richmond, M.S., G.N.P.-B.C.
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules 1U01CA283935-01 Matthew Young, Ph.D.
Villanueva, Augusto

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 1U01CA283931-01 Matthew Young, Ph.D.
Curtius, Kathleen M.

University Of California, San Diego
United States

Multiscale modeling of spatiotemporal evolution in Barrett's esophagus 1R01CA270235-01A1 Ellen Richmond, M.S., G.N.P.-B.C.
Kim, Hyung L

Cedars-Sinai Medical Center
United States

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer 1R01CA280060-01A1
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 1R01CA270248-01A1 Winfred Malone, Ph.D., M.P.H.
Feng, Ziding

Fred Hutchinson Cancer Center
United States

Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 2U24CA230144-07 Guillermo Marquez, Ph.D.
Yu, Danxia

Vanderbilt University Medical Center
United States

Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery 1R01CA275864-01A1 Edward Sauter, M.D., Ph.D.
Chan, Alexandre

University Of California-Irvine
United States

Neurotrophic strategy to mitigate chemotherapy-related brain injury 1R01CA276212-01A1 Catherine Schweppe, Ph.D.
Bergan, Raymond C

University Of Nebraska Medical Center
United States

Preventing invasive prostate cancer 1R01CA276846-01 John Clifford, Ph.D.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 1R01CA283045-01 Catherine Schweppe, Ph.D.
Kuhn, Peter

University Of Southern California
United States

Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma 1U01CA285013-01
Lee, Hakho

Massachusetts General Hospital
United States

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array 1U01CA284982-01
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 1R01CA279666-01A1 Indu Kohaar, Ph.D.
Panigrahy, Dipak

Beth Israel Deaconess Medical Center
United States

Control of cancer cachexia via stimulation of resolution of inflammation 1R01CA276107-01A1
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 1R01CA279220-01A1
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 1R01CA280746-01A1 John Clifford, Ph.D.
Mcguire, Andrew

Fred Hutchinson Cancer Center
United States

Rational Vaccine Design to prevent HIV-Associated Lymphoma 1R01CA285227-01A1 Winfred Malone, Ph.D., M.P.H.
Jacob, Jennifer B

Wayne State University
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 1R01CA278818-01A1 Vignesh Gunasekharan, Ph.D.
Torres, Keila Enitt

University Of Tx Md Anderson Can Ctr
United States

Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs 1R01CA285980-01 Richard Mazurchuk, Ph.D.
Huh, Warner King

University Of Alabama At Birmingham
United States

Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) 1R01CA279021-01A1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.